View drug registration information details.
Items | Registration information |
ID | 245 |
No | 245 |
Brand Name | PEMIDX |
Ingredients | PEMIGATINIB 4.5 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | STORE BELOW 30 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 28 TABLET'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTINEOPLASTIC |
Indications | IN ADULT WHO HAVE ALREADY RECEIVED A PREVIOUS TREATMENT TO TREAT A CERTAIN TYPE OF CHOLANGIOCARCINOMA (BILE DUCT CANCER) THAT HAS SPREAD TO NEARBY TISSUES OR OTHER PARTS OF THE BODY AND CANNOT BE REMOVED BY SURGERY |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
No |
Description | ROUND TABLET, HAVING DX ON ONE SIDE AND 4.5 ON THE OTHER SIDE |
Note | |
License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 10 L 1023/23 |
FDD Registration Date | 2023-10-10 |
Expiry Date | 2026-10-09 |
Back to drug list
|